Come up with a name for your new list and we'll add to it:
PhaseBio Pharmaceuticals raised a round of funding on December 02, 2010. Investors include
Qualifying Therapeutic Discovery Project.
PhaseBio Pharmaceuticals (PHAS) is a clinical-stage biopharmaceutical company developing drugs to treat diabetes and cardiovascular dysfunction in patients suffering from rare diseases. The Company's …